Autor: Firma AlpVision SA

AlpVision offer free of charge security feature to protect COVID-19 relevant medicines against counterfeiting

On November 13th, 2020, AlpVision is launching the “AlpVision COVID-19 Initiative” helping pharmaceutical companies to protect COVID-19 relevant medicines against counterfeiting. COVID-19 has caused not only a worldwide health crisis, but also created unprecedented economic challenges. In response, AlpVision has decided to launch the “AlpVision COVID-19 Initiative”. The initiative supports pharmaceutical companies by providing them […]

Read More